Literature DB >> 177992

Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection.

S E Starr, A M Visintine, M O Tomeh, A J Nahmias.   

Abstract

Since age-dependent diminished macrophage function has been related to the increased susceptibility of newborn mice to herpes simplex virus (HSV) infection, the effect of several agents which might activate macrophages or other cells involved in immunity was investigated. BCG, typhoid vaccine, brucella vaccine, levamisole, or staphage lysate were administered to newborn mice prior to challenge with HSV-2. Of these agents, only BCG, administered ip or id 6 days prior to challenge, was found to increase the survival rate of newborn mice. The possible use of BCG, alone or in combination with other modalities, for the prevention or treatment of neonatal HSV infections is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 177992     DOI: 10.3181/00379727-152-39327

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  23 in total

1.  Replication of herpes simplex virus type 1 in macrophages from resistant and susceptible mice.

Authors:  C Lopez; G Dudas
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

2.  The effect of BCG-vaccination on vaccinia virus infections in mice.

Authors:  G T Werner
Journal:  Experientia       Date:  1979-11-15

Review 3.  Role of macrophages in natural resistance to virus infections.

Authors:  S C Mogensen
Journal:  Microbiol Rev       Date:  1979-03

4.  Protection of mice against mouse hepatitis virus by Corynebacterium parvum.

Authors:  L Schindler; G Streissle; H Kirchner
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Effect of thymopentin on the mortality and immune response after an experimental herpes simplex infection in mice.

Authors:  R Cappel; F de Cuyper; K De Neef; W Höbel; K Bolla
Journal:  Surv Immunol Res       Date:  1985

6.  Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2.

Authors:  M R McDermott; J R Smiley; P Leslie; J Brais; H E Rudzroga; J Bienenstock
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

7.  Protection against herpes simplex virus infection in mice by Corynebacterium parvum.

Authors:  H Kirchner; H M Hirt; K Munk
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

8.  Enhancement of natural resistance to influenza virus in lipopolysaccharide-responsive and -nonresponsive mice by Propionibacterium acnes.

Authors:  J D Gangemi; J A Hightower; R A Jackson; M H Maher; M G Welsh; M M Sigel
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes.

Authors:  H S Larsen; R G Russell; B T Rouse
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  Protectivity of herpes simplex virus antigens: studies in mice on the adjuvant effect of PICLC and on the dependence of protection on T cell competence.

Authors:  J Hilfenhaus; H Christ; R Köhler; H Moser; H Kirchner; H B Levy
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.